ANIP up +3.37% percent Today $ANIP High is at 56.7
Post# of 84
Posted On: 11/17/2014 10:58:20 AM
ANIP up +3.37% percent Today $ANIP High is at 56.74 and the Low 54.01 with current volume of 81,477.
Recent News posted below.
ANI Pharmaceuticals Inc ANIP other info.
http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 12 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26), PBYI: 223.58 (+7.36)
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 56.01 (+2.06), ICPT: 159.47 (-3.11), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 56.01 (+2.06)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 56.01 (+2.06), SCMP: 11.94 (+0.64)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 56.01 (+2.06)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), CLDX: 17.90 (+3.74), AMAG: 34.69 (+0.69)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.57 (+0.11), ANIP: 56.01 (+2.06), ACGL: 56.85 (-0.45), ACCO: 8.96 (-0.03), FLWS: 8.84 (-0.15)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 56.01 (+2.06)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.37 (-0.61), HBNK: 19.95 (+0.17), ASMI: 41.46 (+0.20), RRGB: 68.69 (+0.18), SAPE: 24.68 (unch), PLUG: 3.72 (unch), ANIP: 56.01 (+2.06), ODP: 6.57 (-0.22), MTEX: 21.98 (+1.67), JAXB: 11.75 (-0.15), ALQA: 5.10 (+0.05), YRCW: 23.46 (-0.27)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.13 (+0.05), NEO: 4.69 (+0.01), AU: 9.39 (-0.17), FNHC: 24.57 (-0.16), AMS: 2.53 (-0.19), NYMX: 0.57 (+0.02), AMDA: 1.37 (+0.15), CVD: 100.35 (+0.05), GBIM: 6.50 (+0.20), RCAP: 11.84 (-0.25), KBIO: 1.96 (-0.14), COOL: 0.81 (-0.09), SAPE: 24.68 (unch), XTLB: 2.58 (+0.13), GERN: 3.03 (+0.27), ANIP: 56.01 (+2.06), BBLU: 1.32 (+0.02), NXTD: 2.31 (unch), AP: 18.78 (-0.10), ALQA: 5.10 (+0.05)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 56.01 (+2.06)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 56.01 (+2.06)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 56.01 (+2.06)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI" (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 56.01 (+2.06)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.84 (+0.03), SYY: 38.86 (+0.28), L: 42.55 (-0.23), EEP: 37.93 (+0.59), SNH: 22.21 (+0.03), INN: 11.47 (-0.07), ITG: 19.61 (+0.10), NSP: 32.90 (-0.08), S: 5.01 (-0.04), ALE: 49.97 (+0.14), GVA: 35.92 (-0.35), MCY: 53.86 (-0.19), ARNA: 4.58 (+0.05), CHD: 73.72 (+0.19), ARE: 82.56 (+0.24), USAK: 18.56 (+0.11), BWP: 16.76 (-0.19), KRG: 26.18 (-0.02), CYOU: 22.74 (-1.13), MNKD: 6.22 (+0.06), HNT: 50.87 (+1.07), AMH: 17.24 (-0.03), ARCB: 42.42 (-0.19), ANIP: 56.01 (+2.06), AMG: 195.41 (-1.53), HAE: 36.98 (-0.15), SOHU: 49.42 (-1.54), CNA: 38.94 (-0.18)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.66 (+0.76), MACK: 8.70 (+0.22), ANIP: 56.01 (+2.06), ILMN: 182.54 (+2.04)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 56.01 (+2.06)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 56.01 (+2.06), KTOS: 5.32 (-0.08), BLOX: 17.04 (+0.18), CSLT: 11.17 (-0.69), FPRX: 15.44 (+0.25)
Recent News posted below.
ANI Pharmaceuticals Inc ANIP other info.
http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 12 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26), PBYI: 223.58 (+7.36)
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 56.01 (+2.06), ICPT: 159.47 (-3.11), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 56.01 (+2.06)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 56.01 (+2.06), SCMP: 11.94 (+0.64)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 56.01 (+2.06)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), CLDX: 17.90 (+3.74), AMAG: 34.69 (+0.69)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.57 (+0.11), ANIP: 56.01 (+2.06), ACGL: 56.85 (-0.45), ACCO: 8.96 (-0.03), FLWS: 8.84 (-0.15)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health. ANIP: 56.01 (+2.06)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.37 (-0.61), HBNK: 19.95 (+0.17), ASMI: 41.46 (+0.20), RRGB: 68.69 (+0.18), SAPE: 24.68 (unch), PLUG: 3.72 (unch), ANIP: 56.01 (+2.06), ODP: 6.57 (-0.22), MTEX: 21.98 (+1.67), JAXB: 11.75 (-0.15), ALQA: 5.10 (+0.05), YRCW: 23.46 (-0.27)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.13 (+0.05), NEO: 4.69 (+0.01), AU: 9.39 (-0.17), FNHC: 24.57 (-0.16), AMS: 2.53 (-0.19), NYMX: 0.57 (+0.02), AMDA: 1.37 (+0.15), CVD: 100.35 (+0.05), GBIM: 6.50 (+0.20), RCAP: 11.84 (-0.25), KBIO: 1.96 (-0.14), COOL: 0.81 (-0.09), SAPE: 24.68 (unch), XTLB: 2.58 (+0.13), GERN: 3.03 (+0.27), ANIP: 56.01 (+2.06), BBLU: 1.32 (+0.02), NXTD: 2.31 (unch), AP: 18.78 (-0.10), ALQA: 5.10 (+0.05)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 56.01 (+2.06)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 56.01 (+2.06)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 56.01 (+2.06)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014. ANIP: 56.01 (+2.06)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.84 (+0.03), SYY: 38.86 (+0.28), L: 42.55 (-0.23), EEP: 37.93 (+0.59), SNH: 22.21 (+0.03), INN: 11.47 (-0.07), ITG: 19.61 (+0.10), NSP: 32.90 (-0.08), S: 5.01 (-0.04), ALE: 49.97 (+0.14), GVA: 35.92 (-0.35), MCY: 53.86 (-0.19), ARNA: 4.58 (+0.05), CHD: 73.72 (+0.19), ARE: 82.56 (+0.24), USAK: 18.56 (+0.11), BWP: 16.76 (-0.19), KRG: 26.18 (-0.02), CYOU: 22.74 (-1.13), MNKD: 6.22 (+0.06), HNT: 50.87 (+1.07), AMH: 17.24 (-0.03), ARCB: 42.42 (-0.19), ANIP: 56.01 (+2.06), AMG: 195.41 (-1.53), HAE: 36.98 (-0.15), SOHU: 49.42 (-1.54), CNA: 38.94 (-0.18)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.66 (+0.76), MACK: 8.70 (+0.22), ANIP: 56.01 (+2.06), ILMN: 182.54 (+2.04)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 56.01 (+2.06)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 56.01 (+2.06), KTOS: 5.32 (-0.08), BLOX: 17.04 (+0.18), CSLT: 11.17 (-0.69), FPRX: 15.44 (+0.25)
(0)
(0)